Sonoma Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.79M
on 2026-06-30, from 780K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-20 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
$2.1M
Ladenburg Thalmann, agreement of 2025-09-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
8.3 quarters
$5.3M on 2026-06-30 ÷ $642K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-04-24 | Public offering with warrants at $1.35 | not read | $1.35 | $4.0M | 424B4 ↗ |